Form D/A — Dewpoint Therapeutics, Inc.
0001828893-26-000001 · filed Jul 13, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $82,299,400
- Reported amount sold
- $77,164,102
- Minimum investment
- $0
- Investors
- 23
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Dewpoint Therapeutics, Inc.
- CIK
- 1828893
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 451 D STREET, SUITE 104
BOSTON, MA 02210 - Phone
- 617-914-8448
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ameet Nathwani, M.D. · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Srinivas Akkaraju, M.D., Ph.D. · DirectorBoston, MA Find on LinkedIn ↗
-
Regina Barzilay, Ph.D. · DirectorBoston, MA Find on LinkedIn ↗
-
Olivier Brandicourt, M.D. · DirectorBoston, MA Find on LinkedIn ↗
-
Giuseppe A. Ciaramella, Ph.D. · DirectorBoston, MA Find on LinkedIn ↗
-
Anthony A. Hyman, Ph.D. · DirectorBoston, MA Find on LinkedIn ↗
-
Mark Murcko, Ph.D. · DirectorBoston, MA Find on LinkedIn ↗
-
Amir H. Nashat, Sc.D. · DirectorBoston, MA Find on LinkedIn ↗
-
Steven Neier, Ph.D. · DirectorBoston, MA Find on LinkedIn ↗
-
Richard A. Young, Ph.D. · DirectorBoston, MA Find on LinkedIn ↗
-
Isaac A. Klein, M.D., Ph.D. · Executive OfficerBoston, MA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗